These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7476302)

  • 1. Metabolic effects of insulin-like growth factor-I: a focus on insulin sensitivity.
    Hussain MA; Schmitz O; Christiansen JS; Zapf J; Froesch ER
    Metabolism; 1995 Oct; 44(10 Suppl 4):108-12. PubMed ID: 7476302
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic and therapeutic effects of insulin-like growth factor I.
    Froesch ER; Zenobi PD; Hussain M
    Horm Res; 1994; 42(1-2):66-71. PubMed ID: 7959637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I in the therapy of non-insulin-dependent diabetes mellitus and insulin resistance.
    Froesch ER; Bianda T; Hussain MA
    Diabetes Metab; 1996 Jul; 22(4):261-7. PubMed ID: 8767173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Glucagon : recent acquisitions, with special reference to its metabolic effects and use in diagnosis and therapy].
    Bosello O; Cigolini M; Rossi G
    Recenti Prog Med; 1975 Mar; 58(3):289-316. PubMed ID: 1094512
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic potential of rhIGF-I in diabetes and conditions of insulin resistance.
    Froesch ER; Hussain M
    J Intern Med; 1993 Dec; 234(6):561-70. PubMed ID: 8258747
    [No Abstract]   [Full Text] [Related]  

  • 6. New horizons in our knowledge of diabetes mellitus.
    Levine R
    J Am Geriatr Soc; 1971 Nov; 19(11):897-908. PubMed ID: 4949263
    [No Abstract]   [Full Text] [Related]  

  • 7. The contribution of hyperglycemic hormones to the pathogenesis of diabetes mellitus.
    Sperling MA
    Am J Dis Child; 1977 Oct; 131(10):1145-9. PubMed ID: 910769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor I therapy for diabetes mellitus?
    Kolaczynski JW; Caro JF
    Diabetes Care; 1994 Jan; 17(1):92-6. PubMed ID: 8112197
    [No Abstract]   [Full Text] [Related]  

  • 9. Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?
    Dunger DB; Cheetham TD; Holly JM; Matthews DR
    Acta Paediatr Suppl; 1993 Mar; 388():49-52; discussion 53. PubMed ID: 8329831
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin: physiological and clinical significance.
    Guillemin R; Gerich JE
    Annu Rev Med; 1976; 27():379-88. PubMed ID: 779605
    [No Abstract]   [Full Text] [Related]  

  • 12. [Carbohydrate metabolism in liver diseases].
    Mosin VI
    Klin Med (Mosk); 1974 Feb; 52(2):. PubMed ID: 4619410
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anterior pituitary hormones--with special reference to growth hormone].
    Ikemoto M; Yano S
    Nihon Rinsho; 1990 Dec; 48 Suppl():120-6. PubMed ID: 1964973
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of growth hormone and insulin-like growth factor I on endocrine function of human fetal islet-like cell clusters during long-term tissue culture.
    Otonkoski T; Knip M; Wong I; Simell O
    Diabetes; 1988 Dec; 37(12):1678-83. PubMed ID: 3056761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatomedin-1 (insulin-like growth factor-I) in clinical use. Facts and potential.
    Laron Z
    Drugs; 1993 Jan; 45(1):1-8. PubMed ID: 7680980
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic effects of insulin-like growth factor I in normal humans.
    Sherwin RS; Borg WP; Boulware SD
    Horm Res; 1994; 41 Suppl 2():97-101; discussion 102. PubMed ID: 8088711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of arginine aspartate and its components on growth hormone, insulin and glucagon secretion in the rat.
    Franchimont P; Campistron G; Creuzet MH; Gros J; Luyckx A
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):161-8. PubMed ID: 6372719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor insensitivity in renal failure.
    Rabkin R
    Ren Fail; 2001; 23(3-4):291-300. PubMed ID: 11499545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic effects of insulin-like growth factor I with special reference to diabetes.
    Froesch ER; Hussain M
    Acta Paediatr Suppl; 1994 Apr; 399():165-70. PubMed ID: 7949607
    [No Abstract]   [Full Text] [Related]  

  • 20. Serial changes in glucose utilization and insulin and growth hormone secretion in acute cerebrovascular disease.
    Huff TA; Lebovitz HE; Heyman A; Davis L
    Stroke; 1972; 3(5):543-52. PubMed ID: 4652729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.